Development of a synchronous enzyme-reaction system for a highly sensitive enzyme immunoassay.
A synchronous enzyme-reaction system using water-soluble formazan and a non-enzymatic electron mediator was developed and applied to an enzyme immunoassay (EIA). The reaction system consists of four steps: (I) dephosphorylation of NADP(+) to produce NAD(+) by alkaline phosphatase (ALP), (II) reduction of NAD(+) to produce NADH with oxidation of ethanol to yield acetaldehyde by alcohol dehydrogenase (ADH), (III) reduction of water-soluble tetrazolium salt (WST-1) to produce formazan by NADH via 1-methoxy-5-methyl-phenazinium methyl sulfate (PMS), and (IV) re-reduction of NAD(+) to produce NADH by ADH. During each cycle, one molecule of tetrazolium is converted to one molecule of formazan. The concentration of formazan during the reaction was given by second-order polynomials of the reaction time. Kinetic studies strongly suggested that the synchronous enzyme-reaction system had the potential to detect an analyte at the attomole level in EIA. On the basis of the kinetic studies, optimal conditions for EIA incorporating the synchronous system were examined. NADP(+) was purified thoroughly to remove minor traces of NAD(+) in the preparation, and an ADH preparation contaminated with the lowest level of ALP activity was used. When the synchronous system was applied to a sandwich-type EIA for human C-reactive protein, the protein was detected with a sensitivity of 50 attomole per well of a micro-titer plate (0.1 ml) in a 1-h reaction. In addition, EIA with water-soluble formazan showed a more quantitative and sensitive result than that with insoluble formazan. These findings indicated that the (WST-1)-PMS system introduced in this study has a great potential for highly sensitive enzyme immunoassay.
Inouye
Kuniyo
K
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan. inouye@kais.kyoto-u.ac.jp
Ueno
Iori
I
Yokoyama
Shin-ichi
S
Sakaki
Toshiyuki
T
D000426:Alcohol Dehydrogenase / Q000378:metabolism*; D000469:Alkaline Phosphatase / Q000378:metabolism*; D000911:Antibodies, Monoclonal; D002097:C-Reactive Protein / Q000032:analysis; D004789:Enzyme Activation / Q000187:drug effects / Q000502:physiology; D005562:Formazans / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D007700:Kinetics; D008773:Methylphenazonium Methosulfate / Q000031:analogs & derivatives* / Q000494:pharmacology; D009249:NADP / Q000302:isolation & purification / Q000378:metabolism; D010084:Oxidation-Reduction; D012680:Sensitivity and Specificity; D013778:Tetrazolium Salts
D000911:Antibodies, Monoclonal; D005562:Formazans; D013778:Tetrazolium Salts; D008773:Methylphenazonium Methosulfate; D009249:NADP; C023530:1-methoxy-5-methylphenazinium methyl sulfate; D002097:C-Reactive Protein; D000426:Alcohol Dehydrogenase; D000469:Alkaline Phosphatase